Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 2, 2022Sanofi will receive an upfront payment of $900 million, and an 11% royalty on worldwide net sales of Libtayo
-
Jun 1, 2022Efanesoctocog alfa is the first factor VIII therapy to be awarded Breakthrough Therapy designation by the FDA
-
May 17, 2022Data to be shared across multiple tumor types, including multiple myeloma, lung cancer and breast cancer
-
May 15, 2022Latest results of the Phase 3 IKEMA trial demonstrate the longest median progression free survival (mPFS) on a proteasome inhibitor backbone in patients who relapsed after a prior therapy, including lenalidomide